Bercemhan Sulu
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis.
Journal: Anais brasileiros de dermatologia
Published: March 06, 2026
Efficacy and safety of JAK inhibitors in Behçet syndrome: systematic literature review.
Journal: Seminars in arthritis and rheumatism
Published: January 22, 2026
Clinical distinctions of anti-topoisomerase positive limited cutaneous systemic sclerosis in early disease: results from the early Systemic sclerOsis Longitudinal Assessment Registry from Turkey.
Journal: Clinical and experimental rheumatology
Published: December 06, 2025
Results from a pilot study of dusquetide for the treatment of aphthous ulcers associated with Behçet's syndrome.
Journal: Rheumatology (Oxford, England)
Published: October 24, 2025
Upadacitinib in resistant Takayasu's arteritis with coexisting ulcerative colitis.
Journal: Clinical and experimental rheumatology
Published: October 08, 2025
Efficiency of Ultrasound Screening in Papillary Thyroid Cancer Patients with Excellent Response to Therapy.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: July 30, 2025
Behçet's syndrome within the spectrum of systemic vasculitides.
Journal: Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
Published: December 28, 2024
Hydroxychloroquine dose after hospitalization for systemic lupus erythematosus: comment on the article by Nestor et al.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 28, 2024
New and future perspectives in Behçet's syndrome.
Journal: Archives of rheumatology
Published: December 10, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026